Mi-Sun Byun

26PUBLICATIONS
170CO-AUTHORS
Molecular targetsCancer geneticsEconometric and statistical methodsClinical midwiferyVirtual and mixed reality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.

|Apr 01, 2026
Germline Mutations Related to Complete Remission After Neoadjuvant Chemotherapy in Patients With Triple-negative Breast Cancer.

Jee Hyun Ahn, Ji Soo Park, Dongju Won

|Mar 13, 2026
ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer.

Ann E Collier, Stephanie Hilz, Alejandro M Chibly

|Dec 29, 2025
OPERA-01: a phase III study of palazestrant for ER+, HER2- advanced breast cancer after CDK4/6 inhibitor therapy.

Barbara Pistilli, Meritxell Bellet Ezquerra, Lucia Del Mastro

|Dec 10, 2025
HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Veronique Dieras, Giuseppe Curigliano, Miguel Martin

|Oct 22, 2025
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.

Javier Cortés, Kevin Punie, Carlos Barrios

Pageof 5

Frequent Collaborators

5 joint publications

Aditya Bardia

4 joint publications

Elgene Lim

4 joint publications

Miguel Martín

3 joint publications

Giuseppe Curigliano